Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient's cells.
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way ...
Touchlight, in collaboration with New England Biolabs (NEB®), announces the launch of the EnClose™ Cell-free dbDNA™ Synthesis Kit, a new benchtop solution enabling rapid enzymatic production of ...
Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results